Meeting: October 27-28 | In-Person

The DIA Canada Annual Meeting will provide an in-depth exploration of the current pharmaceutical, medical device, and diagnostic landscapes in Canada, emphasizing Canada’s pivotal role in global healthcare product development. Offering three specialized tracks on Regulatory, Clinical, and Safety and Pharmacovigilance, the meeting will cover topics spanning from Health Canada’s latest regulatory initiatives, international collaboration, and innovative clinical practices to approaches that harness AI in drug safety and increase representation from equity-denied groups.

Attendees will have the opportunity to engage with leaders and experts from academia, regulatory bodies, and the pharmaceutical and medical device industries by gaining insights into best practices, lessons learned, and strategies to address the challenges facing stakeholders in Canada.

While we develop our 2025 agenda, please take a moment to review the 2024 final agenda.